Eylea real-life case studies

S. James Talks, MD

Mr Talks discusses two case studies from his real-life experience with aflibercept in clinical practice during the first year of treatment. Both patients were treatment naive and a fixed dosing regimen based on the VIEW studies was used. At the time of treatment the first patient (female) was 78 years old and the second patient (female) was 83 years old.

Posted: 9/29/2015